Emerging Treatments and the Clinical Trial Landscape for Hidradenitis Suppurativa-Part II: Procedural and Wound Care Therapies

Natalie M Fragoso; Rahul Masson; T Justin Gillenwater; Vivian Y Shi; Jennifer L Hsiao

doi:10.1007/s13555-023-00957-5

Emerging Treatments and the Clinical Trial Landscape for Hidradenitis Suppurativa-Part II: Procedural and Wound Care Therapies

Dermatol Ther (Heidelb). 2023 Aug;13(8):1699-1720. doi: 10.1007/s13555-023-00957-5. Epub 2023 Jul 4.

Authors

Natalie M Fragoso¹, Rahul Masson², T Justin Gillenwater³, Vivian Y Shi⁴, Jennifer L Hsiao⁵

Affiliations

¹ Department of Dermatology, Dartmouth Hitchcock Medical Center, Lebanon, NH, USA.
² Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
³ Division of Plastic and Reconstructive Surgery, University of Southern California, Los Angeles, CA, USA.
⁴ Department of Dermatology, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
⁵ Department of Dermatology, University of Southern California, 1441 Eastlake Ave, Ezralow Tower, Suite 5301, Los Angeles, CA, 90089, USA. j.hsiao.publications@gmail.com.

Abstract

Procedural treatments are a cornerstone of hidradenitis suppurativa (HS) management. New interventional therapies are being studied as part of the upsurge in HS research and clinical trials. Additionally, draining wounds can impart a significant negative impact on patients' quality of life, requiring daily dressing changes. However, standardized guidelines on how to best manage HS wounds both day-to-day and post-procedure are lacking. In part II of this emerging therapies review, procedural treatments and wound care dressings and devices that are being investigated for HS management are discussed.

Keywords: Clinical trials; Dressings; Hidradenitis suppurativa; Procedures; Wound care.

Publication types

Review